Fredrik Erlandsson

Company: Purespring Therapeutics

Job title: Chief Medical Officer

Seminars:

12:00 PM Advancing Precision Nephrology & Podocyte Targeted Gene Therapies 12:00 pm

Sharing data on PS-001 for NPHS2 driven Focal and Segmental Glomerulosclerosis and PS-002 for complement driven glomerular diseases Exploring Phase 1 trial design considerations and including patient input Discussing next-steps in gene therapies for glomerular diseasesRead more

day: Conference Day 2